Evidence map›Paper›PMID 24523796›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2013

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran.

Farzad Khademi, Jamshid Faghri, Farkhondeh Poursina, Bahram Nasr Esfahani, Sharareh Moghim, Hossein Fazeli, Peyman Adibi, Nasrin Mirzaei, Mojtaba Akbari, Hajieh Ghasemian Safaei

Open access · greenAbstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Assessment ofMicroorganisms · 2026
    Article
  3. Antibiotic Resistance Identification Among the Patients withMiddle East journal of digestive diseases · 2025
    Article
  4. Article
  5. Article
  6. The efficacy and safety of furazolidone-bismuth quadruple therapy forGastroenterology and hepatology from bed to bench · 2022
    Article
  7. Antibiotic resistance pattern ofJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022
    Article
  8. Molecular Assessment of Resistance to Clarithromycin inBioMed research international · 2020
    Article
  9. Article
  10. The Interaction ofAdvanced biomedical research · 2019
    Review
  11. Article
  12. Eradication ofMiddle East journal of digestive diseases · 2018
    Review
  13. Review
  14. Iranian journal of pediatrics · 2016
    Article
  15. Review
  16. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2016
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Farzad KhademiDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Jamshid FaghriDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Farkhondeh PoursinaDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Bahram Nasr EsfahaniDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Sharareh MoghimDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hossein FazeliDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Peyman AdibiDepartment of Gastroenterology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nasrin MirzaeiDepartment of Biology, Islamic Azad University, Tonekabon Branch, Tonekabon, Iran.
Mojtaba AkbariDepartment of Biostatistics and Epidemiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hajieh Ghasemian SafaeiDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IRIslamic Azad University Tonekabon · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelicobacter pylori (H. pylori) resistance to antibiotics has become a global problem and is an important factor in determining the outcome of treatment of infected patients. The purpose of this study was to determine the H. pylori resistance to clarithromycin, metronidazole, and amoxicillin in gastrointestinal disorders patients. MATERIALS AND

methodsIn this study, a total of 260 gastric antrum biopsy specimens were collected from patients with gastrointestinal disorders who referred to Endoscopy Section of the Isfahan Hospitals. The E-test and Modified Disk Diffusion Method (MDDM) were used to verify the prevalence of antibiotic resistance in 78 H. pylori isolates to the clarithromycin, metronidazole, and amoxicillin.

resultsH. pylori resistance to clarithromycin, metronidazole, and amoxicillin were 15.3, 55.1, and 6.4%, respectively. In this study, we had one multidrug resistance (MDR) isolates from patient with gastritis and peptic ulcer disease.

conclusionInformation on antibiotic susceptibility profile plays an important role in empiric antibiotic treatment and management of refractive cases. According to the results obtained in this study, H. pylori resistance to clarithromycin and metronidazole was relatively high. MDR strains are emerging and will have an effect on the combination therapy.

Indexed as

AmoxicillinclarithromycinHelicobacter pylorimetronidazole

Identifiers

PMID24523796
PMCPMC3908526
OpenAlexW2169352687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.